Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
Recruiting now · Phase 2 · Has a placebo group
Conditions studied: Diabetic Peripheral Neuropathic Pain
In brief
The purpose of this study is to evaluate the efficacy, safety, and tolerability of VX-993 in participants with pain associated with Diabetic Peripheral Neuropathy (DPN)
Key facts
- Study ID
- NCT06619860
- Run by
- Vertex Pharmaceuticals Incorporated
- People needed
- 300
- Starts
- 2024-10-18
- Expected to finish
- 2027-04-22
- Last updated by the study team
- 2026-06-01
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Centricity Research Brampton — Brampton, Canada (enrolling)
- OCT Research ULC — Kelowna, Canada (enrolling)
- Altasciences - Beaumont Clinic Montreal — Montreal, Canada (enrolling)
- Mount Sinai Hospital - Leadership Sinai Centre for Diabetes (LSCD) — Toronto, Canada (enrolling)
- Centre Hospitalier Universitaire de Clermont-Ferrand - Site Gabriel-Montpied — Clermont-Ferrand, France (enrolling)
- CHU de Nîmes - Pain Assessment and Treatment Center — Nîmes, France (enrolling)
- Hopital Cochin - Rheumatology — Paris, France (enrolling)
- North Hospital — Saint-Priest-en-Jarez, France (enrolling)
- Ruhr-Universitaet Bochum - Heart and Diabetes Center — Bad Oeynhausen, Germany (enrolling)
- FutureMeds GmbH — Berlin, Germany (enrolling)
- FutureMeds Frankfurt — Offenbach/Main, Germany (enrolling)
- Fondazione IRCCS Istituto Neurologico Carlo Besta — Milan, Italy (enrolling)
- IRCCS Ospedale San Raffaele - InSpe and Division of Neuroscience — Milan, Italy (enrolling)
- Birmingham Heartlands Hospital - Heartlands Hospital Diabetes Centre and MIDRU — Birmingham, United Kingdom (enrolling)
- FutureMeds Birmingham — Birmingham, United Kingdom (enrolling)
- Ninewells Hospital - Endocrinology — Dundee, United Kingdom (enrolling)
- FutureMeds Glasgow — Glasgow, United Kingdom (enrolling)
- University of Liverpool - Aintree University Hospital — Liverpool, United Kingdom (enrolling)
- St Pancras Clinical Research — London, United Kingdom (enrolling)
- Manchester Diabetes Centre (MDC) — Manchester, United Kingdom (enrolling)
- George Eliot Hospital NHS Trust — Nuneaton, United Kingdom (enrolling)
- Royal Hallamshire Hospital - Endocrinology — Sheffield, United Kingdom (enrolling)
- Velocity Clinical Research, Dallas — Dallas, Texas, United States
- Cullman Clinical Trials — Cullman, Alabama, United States
- AMR Norfolk — Norfolk, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.